WHO prequalifies first monoclonal antibody – tocilizumab – to treat COVID-19
Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, ...
Read moreAiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, ...
Read moreVabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) ...
Read moreRoche today announced that new data on its investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and ...
Read moreRoche announced that the European Commission has approved Venclyxto® (venetoclax) in combination for the treatment of ...
Read moreTecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in a Phase ...
Read moreCasirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients ...
Read moreRoche announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted ...
Read moreMore than twice as many babies (61% vs. 29%) were able to sit without support for ...
Read moreAnti-p53 antibodies are antibodies that mistakenly target a patient's own tissues, leading to a growth of ...
Read moreThe Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.